Everest Kanto Cylinder with reserves of Rs.1184 cr. against equity of Rs.22.44 cr. reported strong Q3FY26 performance with PAT at Rs.35.73 cr. versus Rs.13.66 cr. Q-o-q growth of 162% and margin improvement to 14.6%. With PE of 11, ongoing capex, expansion at Mundra and upcoming Egypt operations, the stock appears undervalued at Rs.111 compared to its higher levels.

As per market veteran, many investors hesitate to exit loss-making stocks because booking losses feels painful. However shifting capital to businesses with stronger visibility may create better long-term outcomes, as steady compounding over 10–15 years usually outperforms short-term excitement. Protecting capital remains more important than chasing quick profits.

Very important market lesson: No company stays good forever and no company stays bad forever. Examples include Yes Bank, Reliance Infra and DHFL which were once market favourites but later weakened, while State Bank of India and Hindustan Aeronautics moved from weak phases to strong wealth creators. Business cycles, management execution and industry trends drive such shifts, hence investors must adapt and review portfolios regularly.

As per market veteran, foreign investor interest in India has weakened amid rich valuations, rupee concerns and geopolitical risks, especially from oil shocks. Investors are reallocating to markets like Japan, Taiwan, South Korea and Europe. Higher LTCG/STCG and increased STT from April have also reduced India’s relative attractiveness for FPIs.

Very big positive: Benjamin Netanyahu said Israel is ready to open direct negotiations with Lebanon on disarming Hezbollah and establishing peaceful relations. If tensions with Iran ease and war risks decline, it could turn highly positive for the global economy and equity markets.

India Gelatine & Chemicals has reserves of Rs.175 cr. against equity of Rs.7 cr., with promoters holding 69.05% and backing from Japan’s Jellice group. PAT grew 99% to Rs.7.1 cr. in Q3FY26 and 77% to Rs.20.63 cr. in 9MFY26; the stock trades near 9x P/E versus industry 29x and may surpass its high of Rs.514 when sentiment improves.

Ramky Infrastructure has sold a 51% stake in Visakha Pharmacity for Rs.165.24 cr. to focus on its core business and reduce debt. The stock may retest its all-time high during 2026-27. Keep on radar for decent gains.

Kumar Infraprojects has secured a new order worth Rs.2360 cr. Just keep on track.

As per market grapevine, during weak market phases investors look for policy support and stability. Some market participants believe measures such as lowering STT, STCG and LTCG could help attract stronger FII participation, especially when foreign investors are already facing currency depreciation pressures.

Alert: As per market grapevine, Q4FY26 and Q1FY27 results of many firms may remain weak, and with crude staying elevated, Nifty could test 20,500–19,500 if oil does not cool to around $80 by April-end.